-
November 18, 2009
Folic acid supplements may raise cancer risk: study
CHICAGO (Reuters) - Heart patients in Norway -- where unlike many countries foods are not enriched with folic acid -- were more likely to die from cancer if they took folic acid and vitamin B12 supplements compared with those who did not take them, Norwegian researchers said on Tuesday.
-
November 6, 2009
Moderate exercise may lower prostate cancer risk
NEW YORK (Reuters Health) - Men who regularly get moderate exercise may have a lower risk of developing prostate cancer -- including aggressive, fast-growing tumors, a new study finds.
-
November 5, 2009
Red, processed meats linked to prostate cancer
NEW YORK (Reuters Health) - Men who eat a lot of red meat and processed meats may have a higher risk of developing prostate cancer than those who limit such foods, a large study of U.S. men suggests.
-
November 3, 2009
Low cholesterol may be sign of undiagnosed cancer
CHICAGO (Reuters) - Low total cholesterol may be a sign of cancer rather than a cause, as some researchers have suggested, and men who have low cholesterol actually have a lower risk of developing high-risk prostate cancer, two teams reported on Tuesday.
-
October 13, 2009
Pros and cons with "easier" prostate cancer surgery
NEW YORK (Reuters Health) - More and more men with prostate cancer who opt to have the organ surgically removed are choosing less invasive keyhole "prostatectomy" over the more traditional open or "radical" prostatectomy.
-
October 8, 2009
Study isolates virus in chronic fatigue sufferers
WASHINGTON (Reuters) - A virus linked to prostate cancer also appears to play a role in chronic fatigue syndrome, according to research that could lead to the first drug treatments for a mysterious disorder that affects 17 million people worldwide.
-
October 1, 2009
U.S. group sues Bayer over vitamin claims
WASHINGTON/FRANKFURT (Reuters) - A U.S. advocacy group filed a lawsuit against German drugmaker Bayer AG saying the company made false claims about a vitamin supplement it makes.
-
September 29, 2009
Moderate exercise may lower prostate cancer risk
NEW YORK (Reuters Health) - Ready for another reason to exercise? Men who exercise at even moderate levels may have a lower risk of prostate cancer than sedentary men, a new study suggests.
-
September 29, 2009
Men often not told of prostate cancer risks: study
CHICAGO (Reuters) - Doctors do not involve men enough in discussions about whether to undergo screening for prostate cancer, U.S. researchers reported on Monday.
-
September 28, 2009
Income affects prostate cancer survival
NEW YORK (Reuters Health) - Wealthy men with prostate cancer may receive better care than poor men with the disease and may live longer as a result, a study released today hints.
-
September 28, 2009
"Watchful waiting" often works for prostate cancer
NEW YORK (Reuters Health) - New research indicates that over half of men who choose "watchful waiting" as the initial strategy for prostate cancer need no treatment over the long haul.
-
September 25, 2009
Should all men be screened for prostate cancer?
NEW YORK (Reuters Health) - Screening all men for prostate cancer using a currently available common blood test is not worthwhile, according to a new study.
-
September 24, 2009
Fat caused 124,000 cancer cases in Europe: experts
BERLIN (Reuters) - More than 124,000 people in Europe developed cancer last year because they are overweight, and rising body fat levels threaten to add tens of thousands more to their ranks, experts said on Thursday.
-
September 22, 2009
Vitamin B6 tied to better prostate cancer survival
NEW YORK (Reuters Health) - Men with earlier-stage prostate cancer may have better survival odds if they get a little more than the recommended amount of vitamin B6 everyday, a new study suggests.
-
September 18, 2009
Medical societies push standards for robotic surgery
CHICAGO (Reuters) - Surgeons are increasingly turning to high-tech robotic equipment to operate on patients with prostate cancer and other conditions, but some medical authorities worry about inadequate training and lax standards among practitioners.
-
September 17, 2009
Cancer takes a health toll on spouses too
NEW YORK (Reuters Health) - Spouses who have a husband or wife dealing with cancer may see their own physical and psychological health deteriorate over time, a new study suggests.
-
September 15, 2009
Treating prostate cancer conservatively may be OK
NEW YORK (Reuters Health) - New research indicates that treating early stage prostate cancer less aggressively is a good alternative, and that outcomes using such an approach - sometimes referred to as "watchful waiting" - have improved in the last few decades.
-
September 11, 2009
Prostate size does not affect results of surgery
NEW YORK (Reuters Health) - Prostate size affects the technical difficulty of radical prostatectomy -- total surgical removal of the prostate gland as a treatment for prostate cancer -- but not the functional results, according to researchers at Memorial Sloan-Kettering Cancer Center in New York.
-
September 9, 2009
Similar outcomes for new and old prostate surgeries
NEW YORK (Reuters Health) - If you've decided that a surgeon should remove your prostate and you're trying to figure out which kind of surgery is best, a new study may assure you that traditional techniques perform just as well as newer techniques.
-
September 9, 2009
Researchers find prostate cancer stem cell
WASHINGTON (Reuters) - Researchers have found a stem cell, a kind of master cell, that may cause at least some types of prostate cancer.
-
September 7, 2009
Virus might be one cause of prostate cancer-study
WASHINGTON (Reuters) - A virus known to cause leukemia and tumors in animals can be found in some prostate tumors and might be one cause of prostate cancer, U.S. researchers reported on Monday.
-
September 1, 2009
Men who stay trim less apt to get prostate cancer
NEW YORK (Reuters Health) - Men who put on a significant number of pounds after their 20s face a higher risk of prostate cancer than those who remain close to their youthful weight -- but the effects vary by race, a new study indicates.
-
September 1, 2009
Prostate cancer screening: More harm than good?
CHICAGO (Reuters) - Routine screening for prostate cancer has resulted in more than 1 million U.S. men being diagnosed with tumors who might otherwise have suffered no ill effects from them, U.S. researchers said on Monday.
-
August 28, 2009
One drug fights fat and diabetes in mice
WASHINGTON (Reuters) - Researchers searching for a cure for obesity said on Thursday they have developed a drug that not only makes mice lose weight, but reverses diabetes and lowers their cholesterol, too.
-
August 27, 2009
Prostate cancer diagnosed earlier, race gap narrows
NEW YORK (Reuters Health) - Men with prostate cancer are being diagnosed at a younger age and earlier stage today than in years past, and the racial disparity in stage at diagnosis has decreased significantly, researchers report today in the Journal of the National Cancer Institute.
-
August 26, 2009
Hormone drugs dangerous for some prostate patients
WASHINGTON (Reuters) - Hormone-based drugs that help treat aggressive prostate cancer may be dangerous for some men with heart disease, U.S. researchers reported on Tuesday.
-
August 24, 2009
Moving to U.S. tied to higher cancer risks
NEW YORK (Reuters Health) - Hispanic adults who immigrate to the United States may face higher risks of certain cancers than their native countrymen, a new study suggests.
-
August 19, 2009
Cannabis chemicals may help fight prostate cancer
LONDON (Reuters Life!) - Chemicals in cannabis have been found to stop prostate cancer cells from growing in the laboratory, suggesting that cannabis-based medicines could one day help fight the disease, scientists said on Wednesday.
-
August 18, 2009
Tall men at risk of early prostate cancer
NEW YORK (Reuters Health) - Although being tall does not appear to influence the overall risk of prostate cancer, it may have a role in certain manifestations of the disease, US and German researchers have found.
-
August 14, 2009
More people surviving cancer in the UK
NEW YORK (Reuters Health) - The number of cancer survivors in the UK is increasing by about 3% each year, according to new estimates, and grew from 1.2 million in 1992 to approximately 2 million at the end of 2008.
-
August 11, 2009
U.S. Sen Dodd doing well after surgery-spokesman
WASHINGTON (Reuters) - U.S. Senator Christopher Dodd, chairman of the Senate Banking Committee, was recuperating on Tuesday from successful surgery for early stage prostate cancer, his spokesman said in a statement.
-
August 11, 2009
FDA staff cite safety issues with osteoporosis drug
WASHINGTON (Reuters) - Serious infections and cancer cases must be considered as U.S. advisers weigh the future of Amgen's most important experimental drug, regulatory reviewers said in documents released on Tuesday.
-
August 10, 2009
Vietnam seeks funds for Agent Orange victims
HANOI (Reuters) - Vietnam launched an "Orange Day" campaign on Monday to raise funds for people it says suffered through the spraying of Agent Orange herbicide by American forces during the war, for long an irritant in relations.
-
July 31, 2009
U.S. Sen. Dodd has prostate cancer
WASHINGTON (Reuters) - Democratic Senator Christopher Dodd, a leading force for U.S. healthcare reform, said on Friday he has prostate cancer but still plans to run for re-election next year.
-
July 31, 2009
Jury's still out on green tea for preventing cancer
NEW YORK (Reuters Health) - Green tea is safe and may taste delicious, but if you're counting on it to prevent cancer, you may want to reconsider: A new review of studies including more than 1.6 million people has found "limited" evidence that green tea might help prevent some types of cancer.
-
July 28, 2009
Hormone therapy ups prostate cancer survival
NEW YORK (Reuters Health) - Adding hormone therapy to radiation therapy for prostate cancer that has spread to tissues near the prostate gland, but has not yet spread to distant sites in the body, can help prevent the disease from returning and improve survival, according to a report in the journal Cancer.
-
July 28, 2009
Many prostate cancers don't need radical therapy
NEW YORK (Reuters Health) - Important news for men with prostate cancer: first, the cancer tends to grow so slowly that only a fraction of patients actually die from it.
-
July 27, 2009
Agent Orange linked to heart disease, Parkinson's
WASHINGTON (Reuters) - Agent Orange, used by U.S. forces to strip Vietnamese and Cambodian jungles during the Vietnam War, may raise the risk of heart disease and Parkinson's disease, U.S. health advisers said on Friday.
-
July 13, 2009
Heavy drinking may boost prostate cancer risk
NEW YORK (Reuters Health) - Men who drink heavily may be raising their risk of developing prostate cancer, researchers reported Monday.
-
July 13, 2009
Racial gap in colon cancer diagnosis, treatment
NEW YORK (Reuters Health) - Later diagnosis and differences in treatment may be among the reasons that African Americans are less likely than whites to survive colon cancer, a study published Monday suggests.
-
July 7, 2009
Blacks only face survival gap with some cancers
NEW YORK (Reuters Health) - The chances of dying from breast cancer are greater in black women than white women, but other cancers do not show a survival gap between the races, according to two studies published online today in the Journal of the National Cancer Institute (JNCI).
-
July 3, 2009
Prostate cancer screening still unproven: report
NEW YORK (Reuters Health) - PSA blood tests are often used to screen men for prostate cancer, but there is still no good evidence that they cut death rates from the disease, a new review finds.
-
June 24, 2009
Green tea may slow prostate tumor growth
NEW YORK (Reuters Health) - Antioxidant compounds in green tea may help slow the growth and progression of prostate cancer, a preliminary study suggests.
-
June 23, 2009
NSAIDs may interfere with prostate cancer diagnosis
NEW YORK (Reuters Health) - Frequently used, over-the-counter drugs referred to as "nonsteroidal anti-inflammatory drug," (NSAIDs), such as aspirin, ibuprofen and others, may interfere with the early diagnosis of prostate cancer, according to Tennessee-based researchers.
-
June 22, 2009
Last Updated: 2009-06-22 13:36:46 -0400 (Reuters Health)
BANGALORE (Reuters) - Shares of Medarex Inc rose as much as 22 percent Monday, after Mayo Clinic reported that two prostate cancer patients who were treated with the company's experimental drug, ipilimumab, in a mid-stage study showed positive responses.
-
June 16, 2009
Diet may make a difference in prostate cancer
NEW YORK (Reuters Health) - Men may be able to lower their risk of developing prostate cancer, or slow its progression, by watching their diets, a new research review suggests.
-
June 11, 2009
Hormone experts worried about plastics, chemicals
WASHINGTON (Reuters) - Hormone experts said on Wednesday they are becoming worried by a chemical called bisphenol A, which some politicians say they want taken out of products and which consumers are increasingly shunning.
-
June 3, 2009
Acrylamide in food not linked to prostate cancer
NEW YORK (Reuters Health) - Acrylamide exposure from dietary intake shows no significant association with the risk of prostate cancer, US and Swedish researchers report.
-
May 29, 2009
Low oxygen level prostate tumors often recurrent
NEW YORK (Reuters Health) - Hypoxia, or reduced oxygen levels, in prostate tumors significantly predicts a poor long-term biochemical outcome, regardless of other prognostic factors, such as tumor stage or type, according to results of a study presented at the American Society of Clinical Oncology's annual meeting in Orlando.
-
May 27, 2009
Falling U.S. cancer rate saves 650,000 lives
WASHINGTON (Reuters) - A steady 15-year decline in the U.S. death rate from cancer translates to about 650,000 lives over that time, the American Cancer Society said on Wednesday.